<?xml version="1.0" encoding="UTF-8"?>
<ClinicalDocument xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <realmCode code="US"/>
  <typeId root="2.16.840.1.113883.1.3" extension="POCD_HD000040"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.1" extension="2015-08-01"/>
  <templateId root="2.16.840.1.113883.10.20.22.1.9" extension="2015-08-01"/>
  <id root="9cdfbb39-8e33-4bd7-925c-e8d3acdc7db9"/>
  <code code="11506-3" codeSystem="2.16.840.1.113883.6.1" codeSystemName="LOINC" displayName="Progress note"/>
  <title>SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Florence Griffith Joyner</title>
  <effectiveTime value="20260505120000-0500"/>
  <confidentialityCode code="N" codeSystem="2.16.840.1.113883.5.25"/>
  <languageCode code="en-US"/>
  <setId root="733ad1af-e385-41c7-a821-e2ad8719052c"/>
  <versionNumber value="1"/>
  <recordTarget>
    <patientRole>
      <id root="6b80d93f-5f3c-4ecd-9099-3eb60e77368d" extension="HR-ML033-SYN"/>
      <id root="2.16.840.1.113883.4.1" extension="000-33-2648"/>
      <addr nullFlavor="UNK"/>
      <telecom nullFlavor="UNK"/>
      <patient>
        <name use="L"><given>Florence</given><family>Griffith Joyner</family></name>
        <administrativeGenderCode code="F" codeSystem="2.16.840.1.113883.5.1" displayName="Female"/>
        <birthTime value="19891221"/>
        <raceCode nullFlavor="ASKU"/>
        <ethnicGroupCode nullFlavor="ASKU"/>
        <languageCommunication><languageCode code="en"/><preferenceInd value="true"/></languageCommunication>
      </patient>
      <providerOrganization>
        <id root="6a7f851b-842b-45d7-9552-3e8582647414"/>
        <name>St. Posthumous Health Center</name>
      <telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr>
      </providerOrganization>
    </patientRole>
  </recordTarget>
  <author>
    <time value="20260505120000-0500"/>
    <assignedAuthor><id root="243f6931-5dab-4969-baf0-06b01806e884"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Celeste</given><family>Vanterpool</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedAuthor>
  </author>
  <custodian>
    <assignedCustodian><representedCustodianOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedCustodianOrganization></assignedCustodian>
  </custodian>
  <legalAuthenticator>
    <time value="20260505120000-0500"/>
    <signatureCode code="S"/>
    <assignedEntity><id root="243f6931-5dab-4969-baf0-06b01806e884"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Celeste</given><family>Vanterpool</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity>
  </legalAuthenticator>
  <documentationOf>
    <serviceEvent classCode="PCPR"><templateId root="2.16.840.1.113883.10.20.21.3.1"/><effectiveTime><low value="20260505"/><high value="20260505"/></effectiveTime><performer typeCode="PRF"><assignedEntity><id root="243f6931-5dab-4969-baf0-06b01806e884"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Celeste</given><family>Vanterpool</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></performer></serviceEvent>
  </documentationOf>
  <componentOf>
    <encompassingEncounter>
      <id root="98c4ffa8-707a-4edc-8bc2-3e38a05917f9"/>
      <code code="390906007" codeSystem="2.16.840.1.113883.6.96" displayName="Follow-up encounter"><originalText>EEG and MRI results: focal epilepsy from a left orbitofrontal cavernous malformation; epilepsy consultation, levetiracetam with folic acid, and neurosurgical opinion requested</originalText></code>
      <effectiveTime><low value="20260505"/><high value="20260505"/></effectiveTime>
      <encounterParticipant typeCode="ATND"><assignedEntity><id root="243f6931-5dab-4969-baf0-06b01806e884"/><addr nullFlavor="UNK"/><telecom nullFlavor="UNK"/><assignedPerson><name><given>Celeste</given><family>Vanterpool</family><suffix>MD</suffix></name></assignedPerson><representedOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></representedOrganization></assignedEntity></encounterParticipant>
      <location><healthCareFacility><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><serviceProviderOrganization><id root="6a7f851b-842b-45d7-9552-3e8582647414"/><name>St. Posthumous Health Center</name><telecom use="WP" value="tel:+1-202-555-0100"/>
      <addr use="WP"><streetAddressLine>100 Forge Way</streetAddressLine><city>Aetherton</city><state>OR</state><postalCode>00000</postalCode><country>US</country></addr></serviceProviderOrganization></healthCareFacility></location>
    </encompassingEncounter>
  </componentOf>
  <component>
    <structuredBody>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.1.13.2.1"/>
    <code code="10154-3" codeSystem="2.16.840.1.113883.6.1" displayName="Chief complaint Narrative - Reported"/>
    <title>Chief Complaint</title>
    <text><paragraph>EEG and MRI results and epilepsy consultation. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.4"/>
    <code code="10164-2" codeSystem="2.16.840.1.113883.6.1" displayName="History of Present illness Narrative"/>
    <title>History of Present Illness</title>
    <text><paragraph>Ms. Griffith Joyner returns two weeks after her first visit. The sleep-deprived EEG two days after that visit showed intermittent left frontal sharp waves and slowing. MRI of the brain six days after the visit, with susceptibility-weighted imaging, shows a single 1.4 cm cavernous malformation in the left orbitofrontal cortex with a hemosiderin rim and an adjacent developmental venous anomaly, and no other lesion. Dr. Mehta-Sorensen of the epilepsy service saw her this morning. She has had no further seizure, spell or headache. She has not driven, showers rather than bathes, and has not swum. The records of her earlier seizure care have been requested and have not arrived. She is not pregnant (negative test at the first visit) and is not planning a pregnancy now. She has had no thoughts of self-harm. [S]</paragraph><table><thead><tr><th>Element</th><th>Detail</th></tr></thead><tbody><tr><td>EEG</td><td>Left frontal sharp waves and focal slowing</td></tr><tr><td>MRI</td><td>Single 1.4 cm left orbitofrontal cavernous malformation with a hemosiderin rim; no other lesion on susceptibility-weighted imaging</td></tr><tr><td>Since the last visit</td><td>No seizure; not driving</td></tr><tr><td>Coordination</td><td>Epilepsy consultation today; neurosurgical opinion requested</td></tr><tr><td>Her questions</td><td>Whether this is epilepsy, whether the lesion can be removed, and when she can train and drive</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="1.3.6.1.4.1.19376.1.5.3.1.3.18"/>
    <code code="10187-3" codeSystem="2.16.840.1.113883.6.1" displayName="Review of systems Narrative - Reported"/>
    <title>Review of Systems</title>
    <text><table><thead><tr><th>System</th><th>Result</th><th>Finding</th></tr></thead><tbody><tr><td>Constitutional</td><td>Negative</td><td>No fever or weight change</td></tr><tr><td>Neurological</td><td>Negative</td><td>No seizures, spells, headache, weakness or change in smell or vision</td></tr><tr><td>Musculoskeletal</td><td>Negative</td><td>Muscle aches after the seizure have gone</td></tr><tr><td>Genitourinary</td><td>Negative</td><td>Regular periods; not pregnant</td></tr><tr><td>Psychiatric</td><td>Positive</td><td>Worried about another seizure in public; PHQ-9 3; no thoughts of self-harm</td></tr></tbody></table><paragraph>5 systems reviewed. [S]</paragraph></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.1" extension="2014-06-09"/><templateId root="2.16.840.1.113883.10.20.22.2.1.1" extension="2014-06-09"/>
    <code code="10160-0" codeSystem="2.16.840.1.113883.6.1" displayName="History of Medication use Narrative"/>
    <title>Medications</title>
    <text><table><thead><tr><th>Medication</th><th>Frequency</th><th>Route</th><th>Dates</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="medication-1"><td>Levetiracetam 500 mg oral tablet, one tablet by mouth twice daily</td><td>One tablet twice daily</td><td>Oral route</td><td>2026-05-05</td><td>active</td><td>S</td></tr><tr ID="medication-2"><td>Folic acid 0.4 mg oral tablet, one tablet daily</td><td>One tablet daily</td><td>Oral route</td><td>2026-05-05</td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="af08bfbe-e04f-4abc-943a-72138357c7f8"/>
      <text><reference value="#medication-1"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260505"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="12" unit="h"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="311289" codeSystem="2.16.840.1.113883.6.88" displayName="levetiracetam 500 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="1a9848c4-95a3-4258-b1d3-5231d412131e"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="G40.209" codeSystem="2.16.840.1.113883.6.90" displayName="Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  <entry typeCode="DRIV">
    <substanceAdministration classCode="SBADM" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.16" extension="2014-06-09"/>
      <id root="a8f8e1b2-32d7-4f5d-9f7e-e49836ae39e4"/>
      <text><reference value="#medication-2"/></text>
      <statusCode code="active"/>
      <effectiveTime xsi:type="IVL_TS"><low value="20260505"/></effectiveTime>
      <effectiveTime xsi:type="PIVL_TS" institutionSpecified="false" operator="A"><period value="1" unit="d"/></effectiveTime>
      <routeCode code="C38288" codeSystem="2.16.840.1.113883.3.26.1.1" codeSystemName="NCI Thesaurus" displayName="Oral route"/>
      <doseQuantity value="1"/>
      <consumable>
        <manufacturedProduct classCode="MANU">
          <templateId root="2.16.840.1.113883.10.20.22.4.23" extension="2014-06-09"/>
          <manufacturedMaterial><code code="198640" codeSystem="2.16.840.1.113883.6.88" displayName="folic acid 0.4 MG Oral Tablet"/></manufacturedMaterial>
        </manufacturedProduct>
      </consumable>
      <entryRelationship typeCode="RSON">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.19" extension="2014-06-09"/>
          <id root="42e27fc7-3dfd-4bb4-bb2b-1d0649ef1090"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <statusCode code="completed"/>
          <value xsi:type="CD" code="G40.209" codeSystem="2.16.840.1.113883.6.90" displayName="Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus"/>
        </observation>
      </entryRelationship>
    </substanceAdministration>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.6" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.6.1" extension="2015-08-01"/>
    <code code="48765-2" codeSystem="2.16.840.1.113883.6.1" displayName="Allergies and adverse reactions Document"/>
    <title>Allergies and Intolerances</title>
    <text><table><thead><tr><th>Allergy</th><th>Reaction</th><th>Status</th><th>Evidence</th></tr></thead><tbody><tr ID="allergy-1"><td>No known allergy</td><td></td><td>active</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.30" extension="2015-08-01"/>
      <id root="de3780ee-8aeb-4968-ba08-558be549d115"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260422"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN" negationInd="true">
          <templateId root="2.16.840.1.113883.10.20.22.4.7" extension="2014-06-09"/>
          <id root="0f96a77f-75b8-4e8f-9bfa-faf009233392"/>
          <code code="ASSERTION" codeSystem="2.16.840.1.113883.5.4"/>
          <text><reference value="#allergy-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low nullFlavor="UNK"/></effectiveTime>
          <value xsi:type="CD" code="419199007" codeSystem="2.16.840.1.113883.6.96" displayName="Allergy to substance"/>
          <participant typeCode="CSM"><participantRole classCode="MANU"><playingEntity classCode="MMAT"><code nullFlavor="NA"/></playingEntity></participantRole></participant>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.4" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.4.1" extension="2015-08-01"/>
    <code code="8716-3" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs"/>
    <title>Vital Signs</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="vital-2-1"><td>2026-05-05</td><td>Body height</td><td>170</td><td>cm</td><td>S</td></tr>
  <tr ID="vital-2-2"><td>2026-05-05</td><td>Body weight</td><td>61.2</td><td>kg</td><td>S</td></tr>
  <tr ID="vital-2-3"><td>2026-05-05</td><td>Body mass index (BMI) [Ratio]</td><td>21.2</td><td>kg/m2</td><td>S</td></tr>
  <tr ID="vital-2-4"><td>2026-05-05</td><td>Systolic blood pressure</td><td>110</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-2-5"><td>2026-05-05</td><td>Diastolic blood pressure</td><td>68</td><td>mm[Hg]</td><td>S</td></tr>
  <tr ID="vital-2-6"><td>2026-05-05</td><td>Heart rate</td><td>58</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-2-7"><td>2026-05-05</td><td>Respiratory rate</td><td>14</td><td>/min</td><td>S</td></tr>
  <tr ID="vital-2-8"><td>2026-05-05</td><td>Body temperature</td><td>36.6</td><td>Cel</td><td>S</td></tr>
  <tr ID="vital-2-9"><td>2026-05-05</td><td>Oxygen saturation in Arterial blood by Pulse oximetry</td><td>99</td><td>%</td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.26" extension="2015-08-01"/>
      <id root="d1b99277-9f36-487c-95a8-4c76e2aded98"/>
      <code code="74728-7" codeSystem="2.16.840.1.113883.6.1" displayName="Vital signs, weight, height, head circumference, oximetry, BMI, and BSA panel - HL7.FHIR.R4"/>
      <statusCode code="completed"/><effectiveTime value="20260505"/>
      <component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="cd653a5f-71c3-4b67-9654-ed642d03cb14"/><code code="8302-2" codeSystem="2.16.840.1.113883.6.1" displayName="Body height"/><text><reference value="#vital-2-1"/></text><statusCode code="completed"/><effectiveTime value="20260505"/><value xsi:type="PQ" value="170" unit="cm"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="038cbeae-9733-4964-be2b-95b1ef575770"/><code code="29463-7" codeSystem="2.16.840.1.113883.6.1" displayName="Body weight"/><text><reference value="#vital-2-2"/></text><statusCode code="completed"/><effectiveTime value="20260505"/><value xsi:type="PQ" value="61.2" unit="kg"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="90379074-9f46-46ac-a8e2-7f45d7c7701e"/><code code="39156-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body mass index (BMI) [Ratio]"/><text><reference value="#vital-2-3"/></text><statusCode code="completed"/><effectiveTime value="20260505"/><value xsi:type="PQ" value="21.2" unit="kg/m2"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="50623abf-566a-4bbd-ac65-8a9965d6a3ab"/><code code="8480-6" codeSystem="2.16.840.1.113883.6.1" displayName="Systolic blood pressure"/><text><reference value="#vital-2-4"/></text><statusCode code="completed"/><effectiveTime value="20260505"/><value xsi:type="PQ" value="110" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="e70a0087-026f-48d6-8677-95a907b97037"/><code code="8462-4" codeSystem="2.16.840.1.113883.6.1" displayName="Diastolic blood pressure"/><text><reference value="#vital-2-5"/></text><statusCode code="completed"/><effectiveTime value="20260505"/><value xsi:type="PQ" value="68" unit="mm[Hg]"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="16eb24e5-1828-400a-bef9-a110570514e6"/><code code="8867-4" codeSystem="2.16.840.1.113883.6.1" displayName="Heart rate"/><text><reference value="#vital-2-6"/></text><statusCode code="completed"/><effectiveTime value="20260505"/><value xsi:type="PQ" value="58" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="a68084e8-7d62-4ac7-b9b2-8b57ae008cb9"/><code code="9279-1" codeSystem="2.16.840.1.113883.6.1" displayName="Respiratory rate"/><text><reference value="#vital-2-7"/></text><statusCode code="completed"/><effectiveTime value="20260505"/><value xsi:type="PQ" value="14" unit="/min"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="3d4cf9cf-dd22-442b-b7be-ca66a0ebb943"/><code code="8310-5" codeSystem="2.16.840.1.113883.6.1" displayName="Body temperature"/><text><reference value="#vital-2-8"/></text><statusCode code="completed"/><effectiveTime value="20260505"/><value xsi:type="PQ" value="36.6" unit="Cel"/></observation></component><component><observation classCode="OBS" moodCode="EVN"><templateId root="2.16.840.1.113883.10.20.22.4.27" extension="2014-06-09"/><id root="1a59c766-c7b2-4ef6-9209-aa32a4567cfd"/><code code="59408-5" codeSystem="2.16.840.1.113883.6.1" displayName="Oxygen saturation in Arterial blood by Pulse oximetry"/><text><reference value="#vital-2-9"/></text><statusCode code="completed"/><effectiveTime value="20260505"/><value xsi:type="PQ" value="99" unit="%"/></observation></component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.3" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.3.1" extension="2015-08-01"/>
    <code code="30954-2" codeSystem="2.16.840.1.113883.6.1" displayName="Relevant Diagnostic Tests and/or Laboratory Data"/>
    <title>Results</title>
    <text><table><thead><tr><th>Date</th><th>Measure</th><th>Value</th><th>Unit</th><th>Reference range</th><th>Flag</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="result-15"><td>2026-05-05</td><td>Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]</td><td>3</td><td>{score}</td><td></td><td></td><td>S</td></tr></tbody></table></text>

  <entry typeCode="DRIV">
    <organizer classCode="CLUSTER" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.1" extension="2015-08-01"/>
      <id root="c3419b60-e671-4a1e-bb0e-165a2615b960"/>
      <code code="44261-6" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260505"/><high value="20260505"/></effectiveTime>

      <component>
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.2" extension="2015-08-01"/>
          <id root="0e4d5b51-ec2a-4fef-8a7d-3d73af8cba0b"/>
          <code code="44261-6" codeSystem="2.16.840.1.113883.6.1" displayName="Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]"/>
          <text><reference value="#result-15"/></text>
          <statusCode code="completed"/>
          <effectiveTime value="20260505"/>
          <value xsi:type="PQ" value="3" unit="{score}"/>
        </observation>
      </component>
    </organizer>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.2.10" extension="2015-08-01"/>
    <code code="29545-1" codeSystem="2.16.840.1.113883.6.1" displayName="Physical findings note"/>
    <title>Physical Exam</title>
    <text><paragraph>Vital signs recorded on 2026-05-05; see the Vital Signs section. [S]</paragraph><table><thead><tr><th>System</th><th>Finding</th></tr></thead><tbody><tr><td>General</td><td>Fit and well; weight 61.2 kg; blood pressure 110/68, pulse 58</td></tr><tr><td>Neurological</td><td>Alert and oriented; smell intact to coffee in each nostril; cranial nerves, strength, reflexes, sensation, coordination and gait normal</td></tr><tr><td>Mouth</td><td>No tongue or mouth injury</td></tr><tr><td>Psychiatric</td><td>Composed and attentive; asks precise questions</td></tr></tbody></table></text>

  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.5" extension="2015-08-01"/><templateId root="2.16.840.1.113883.10.20.22.2.5.1" extension="2015-08-01"/>
    <code code="11450-4" codeSystem="2.16.840.1.113883.6.1" displayName="Problem List"/>
    <title>Problems</title>
    <text><table><thead><tr><th>Problem</th><th>Clinical status</th><th>Verification</th><th>Code</th><th>Provenance</th></tr></thead><tbody>
  <tr ID="problem-1">
    <td>Generalized tonic-clonic seizure on a flight two and a half weeks ago, in a 36-year-old woman who was observed overnight in hospital elsewhere and has had treatment for seizures in the past, records requested; no antiseizure medication now; normal examination today. Evaluated as a new seizure: EEG and MRI of the brain with susceptibility-weighted imaging ordered, neurology (epilepsy) review booked, and no driving</td><td>resolved</td><td>confirmed</td>
    <td>R56.9</td><td>S — Synthetic presenting problem anchored to her publicly reported seizure on a flight; superseded by the diagnosis at the epilepsy consultation.</td>
  </tr>
  <tr ID="problem-2">
    <td>Focal epilepsy with structural cause: focal to bilateral tonic-clonic seizure from a left orbitofrontal cavernous malformation, with left frontal epileptiform discharges on EEG; epilepsy under the ILAE 2014 practical definition (an unprovoked seizure with a recurrence risk above 60% from an epileptogenic lesion, and earlier seizures by history); synthetic modern detail linked to her publicly reported seizures and the coroner&apos;s finding</td><td>active</td><td>confirmed</td>
    <td>G40.209</td><td>S — Synthetic seizure type, EEG and classification; the seizures and the cavernous angioma of the left orbital frontal cerebrum are documented (D).</td>
  </tr>
  <tr ID="problem-3">
    <td>Solitary cerebral cavernous malformation, 1.4 cm, left orbitofrontal cortex, with a hemosiderin rim and an adjacent developmental venous anomaly, no other lesion on susceptibility-weighted imaging (sporadic pattern); no acute hemorrhage</td><td>active</td><td>confirmed</td>
    <td>Q28.3</td><td>S — Synthetic imaging detail; the coroner reported a congenital cavernous angioma of the left orbital frontal cerebrum (D).</td>
  </tr></tbody></table></text>

  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="c6e6d694-4806-40c7-bd4c-2b697c87bdec"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="completed"/>
      <effectiveTime><low value="20260422"/><high value="20260505"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="3c6e53f9-cc13-4219-b417-f2e862f2e982"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-1"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260422"/><high value="20260505"/></effectiveTime>
          <value xsi:type="CD" code="R56.9" codeSystem="2.16.840.1.113883.6.90" displayName="Unspecified convulsions"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="227ebff0-f80d-449c-9c18-db58d54c795f"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260505"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="50424bc8-c793-4a5e-9710-6e39d6cf9e44"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-2"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260505"/></effectiveTime>
          <value xsi:type="CD" code="G40.209" codeSystem="2.16.840.1.113883.6.90" displayName="Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures, not intractable, without status epilepticus"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  <entry typeCode="DRIV">
    <act classCode="ACT" moodCode="EVN">
      <templateId root="2.16.840.1.113883.10.20.22.4.3" extension="2015-08-01"/>
      <id root="d36ecb78-2e81-4b94-8f25-0bc390390366"/>
      <code code="CONC" codeSystem="2.16.840.1.113883.5.6" displayName="Concern"/>
      <statusCode code="active"/>
      <effectiveTime><low value="20260505"/></effectiveTime>
      <entryRelationship typeCode="SUBJ">
        <observation classCode="OBS" moodCode="EVN">
          <templateId root="2.16.840.1.113883.10.20.22.4.4" extension="2015-08-01"/>
          <id root="afbb685c-9d5b-4ec3-82bd-6c9df84dff3b"/>
          <code code="55607006" codeSystem="2.16.840.1.113883.6.96" displayName="Problem"/>
          <text><reference value="#problem-3"/></text>
          <statusCode code="completed"/>
          <effectiveTime><low value="20260505"/></effectiveTime>
          <value xsi:type="CD" code="Q28.3" codeSystem="2.16.840.1.113883.6.90" displayName="Other malformations of cerebral vessels"/>
        </observation>
      </entryRelationship>
    </act>
  </entry>
  </section>
</component>

<component>
  <section>
    <templateId root="2.16.840.1.113883.10.20.22.2.9" extension="2014-06-09"/>
    <code code="51847-2" codeSystem="2.16.840.1.113883.6.1" displayName="Evaluation + Plan note"/>
    <title>Assessment and Plan</title>
    <text><list listType="ordered"><item><content styleCode="Bold">Focal epilepsy with structural cause from a left orbitofrontal cavernous malformation (G40.209)</content>. The seizure was a focal to bilateral tonic-clonic seizure arising from the left orbitofrontal cortex, where the EEG shows epileptiform discharges and the MRI shows a cavernous malformation. Under the ILAE 2014 practical definition this is epilepsy after a single unprovoked seizure, because an epileptogenic lesion with matching EEG discharges carries a recurrence risk above 60%; her earlier seizures by history point the same way. Dr. Mehta-Sorensen recommends an antiseizure medication now and a neurosurgical opinion on lesionectomy. Levetiracetam is chosen for a woman who could become pregnant: low risk of birth defects, no interaction with hormonal contraception, and an effective dose from the first day; lamotrigine would need weeks of slow titration and its level falls with estrogen-containing contraception. Valproate is avoided because it carries the highest risk of major malformations and of lower intelligence in children exposed in pregnancy. Folic acid 0.4 mg daily. Levetiracetam can cause irritability or low mood, so mood is checked at each visit; baseline PHQ-9 is 3. [S]<list><item>Levetiracetam 500 mg twice daily from today.</item><item>Folic acid 0.4 mg daily.</item><item>Neurosurgical opinion on lesionectomy within three weeks.</item><item>Seizure diary; seizure action plan and first aid card.</item><item>Nocturnal seizure detection watch ordered.</item><item>Still no driving.</item></list></item><item><content styleCode="Bold">Solitary cerebral cavernous malformation, left orbitofrontal (Q28.3)</content>. A single lesion with a developmental venous anomaly and no other lesions on susceptibility-weighted imaging is the sporadic pattern, so genetic testing for familial cavernous malformation is not needed. No acute hemorrhage. Because it causes her epilepsy and lies in accessible cortex, removing it with its hemosiderin rim offers a good chance of freedom from seizures. [S]<list><item>Neurosurgery evaluation.</item><item>Report sudden severe headache, new weakness, numbness, speech or vision change at once.</item></list></item><item><content styleCode="Bold">Generalized seizure on a flight (R56.9)</content>. Explained by the diagnosis made today; superseded. [S]<list><item>Problem resolved.</item></list></item></list><paragraph>Protocol monitoring: items the monitoring protocol calls for at this visit. [S]</paragraph><table><thead><tr><th>Domain</th><th>Measure</th><th>Interval</th><th>Status</th><th>Detail</th></tr></thead><tbody><tr><td>Laboratory</td><td>Blood count, electrolytes, glucose, calcium, magnesium, kidney and liver tests, creatine kinase, pregnancy test</td><td>At presentation after a seizure</td><td>Up to date</td><td>All normal at the first visit; pregnancy test negative</td></tr><tr><td>Imaging</td><td>EEG (sleep-deprived)</td><td>After a first seizure, as soon as practical</td><td>Up to date</td><td>Two days after the first visit: left frontal sharp waves and focal slowing</td></tr><tr><td>Imaging</td><td>MRI of the brain, epilepsy protocol with susceptibility-weighted imaging</td><td>After a first seizure</td><td>Up to date</td><td>Six days after the first visit: single left orbitofrontal cavernous malformation with a hemosiderin rim</td></tr><tr><td>Examination</td><td>Seizure classification and diagnosis of epilepsy</td><td>When EEG and imaging are available</td><td>Completed today</td><td>Focal to bilateral tonic-clonic seizure; focal epilepsy with structural cause (ILAE 2014: one unprovoked seizure with recurrence risk above 60%)</td></tr><tr><td>Referral</td><td>Neurology (epilepsy)</td><td>Within two weeks of a first seizure</td><td>Completed today</td><td>Seen this morning; recommendations in the consultation note</td></tr><tr><td>Referral</td><td>Neurosurgical evaluation of an epileptogenic cavernous malformation</td><td>When a cavernous malformation causes epilepsy</td><td>Ordered</td><td>Requested today, within three weeks</td></tr><tr><td>Medication safety</td><td>Antiseizure medication choice for a woman who could become pregnant</td><td>At the start of treatment</td><td>Completed today</td><td>Levetiracetam 500 mg twice daily; valproate avoided; no contraceptive interaction</td></tr><tr><td>Medication safety</td><td>Folic acid</td><td>Daily for anyone taking an antiseizure medication who could become pregnant</td><td>Completed today</td><td>0.4 mg daily started</td></tr><tr><td>Self-management</td><td>Contraception and pregnancy planning</td><td>At the start of treatment and yearly</td><td>Completed today</td><td>No pregnancy planned; any method is compatible with levetiracetam; plan a pregnancy with the epilepsy team</td></tr><tr><td>Survey</td><td>Mood and behavior on levetiracetam (PHQ-9)</td><td>Before starting and at each visit</td><td>Completed today</td><td>PHQ-9 3 before the first dose</td></tr><tr><td>Self-management</td><td>Driving restriction and the California physician report</td><td>From the first seizure until cleared</td><td>Up to date</td><td>Not driving; the report California requires was sent after the first visit</td></tr><tr><td>Self-management</td><td>Seizure safety: water, heights, sleep and first aid</td><td>At diagnosis and each visit</td><td>Completed today</td><td>Showers only; swimming only with a companion who knows first aid; no climbing or working at height; written seizure action plan</td></tr><tr><td>Self-management</td><td>Nocturnal seizure detection</td><td>When seizures may occur in sleep</td><td>Ordered</td><td>Wrist-worn detection watch ordered</td></tr><tr><td>Self-management</td><td>SUDEP counseling</td><td>At diagnosis of epilepsy</td><td>Deferred</td><td>Not discussed today: the visit was taken up by the diagnosis, the medication and the surgical question. A deviation from the AAN/AES guideline, which calls for the discussion at diagnosis. Corrective action: booked as the first item at the next visit in three weeks</td></tr></tbody></table><paragraph>Goal progress:</paragraph><list><item>EEG and MRI with susceptibility-weighted imaging within one week, and an epilepsy consultation within two weeks. Outcome by 2026-05-05: EEG in two days, MRI in six, consultation at two weeks [S]</item><item>No further seizures on an antiseizure medication she tolerates. In progress; target 2026-10-20 [S]</item><item>Neurosurgical evaluation of the cavernous malformation and a shared decision about lesionectomy within two months. In progress; target 2026-07-21 [S]</item><item>Safety plan in place: no driving until cleared, water and height safety, SUDEP discussion, and a nocturnal seizure detection plan. In progress; target 2026-05-27 [S]</item><item>Graded return to full sprint training within four months of surgery. In progress; target 2026-10-20 [S]</item></list><paragraph>Guideline basis: Krumholz A, et al. Evidence-based guideline: Management of an unprovoked first seizure in adults. Neurology 2015;84(16):1705-1713 (PMID 25901057) (2015); Fisher RS, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014;55(4):475-482 (PMID 24730690) (2014); Akers A, et al. Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel. Neurosurgery 2017;80(5):665-680 (PMID 28387823) (2017); Harden C, et al. Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factors. Neurology 2017;88(17):1674-1680 (PMID 28438841) (2017); Pack AM, et al. Teratogenesis, Perinatal, and Neurodevelopmental Outcomes After In Utero Exposure to Antiseizure Medication: Practice Guideline From the AAN, AES, and SMFM. Neurology 2024;102(11):e209279 (PMID 38748979) (2024); Beniczky S, et al. Automated seizure detection using wearable devices: A clinical practice guideline of the International League Against Epilepsy and the International Federation of Clinical Neurophysiology. Epilepsia 2021;62(3):632-646 (PMID 33666944) (2021); Governor&apos;s message returning Senate Bill 357 without signature (physician reporting of disorders characterized by lapses of consciousness remains mandatory under Health and Safety Code section 103900) (2024); Depression and Suicide Risk in Adults: Screening (2023)</paragraph><paragraph>Follow-up: Neurosurgical opinion within three weeks; primary care review in three weeks to check levetiracetam, mood and the surgical plan, and to discuss SUDEP. Call at once for another seizure; call emergency services for a seizure lasting five minutes or more. Next scheduled visit 2026-05-27: three weeks on levetiracetam: mood and side effects, the neurosurgical opinion and surgery date, SUDEP and safety counseling. [S]</paragraph></text>

  </section>
</component>
    </structuredBody>
  </component>
</ClinicalDocument>
